Cargando…
Switch‐associated protein 70 protects against nonalcoholic fatty liver disease through suppression of TAK1
BACKGROUND AND AIMS: NAFLD is a progressive disease without known effective drug treatments. Switch‐associated protein 70 (SWAP70) is a guanine nucleotide exchange factor that participates in the regulation of many cellular processes. However, the role of SWAP70 in NAFLD remains unclear. This study...
Autores principales: | Qian, Qiaofeng, Li, Yang, Fu, Jiajun, Leng, Dewen, Dong, Zhe, Shi, Jiajun, Shi, Hongjie, Cao, Dengwei, Cheng, Xu, Hu, Yufeng, Luo, Qiujie, Hu, Manli, Ran, Yong, Tang, Hao, Liu, Hui, Liu, Jinping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321549/ https://www.ncbi.nlm.nih.gov/pubmed/34689362 http://dx.doi.org/10.1002/hep.32213 |
Ejemplares similares
-
SWAP70 Overexpression Protects Against Pathological Cardiac Hypertrophy in a TAK1‐Dependent Manner
por: Qian, Qiaofeng, et al.
Publicado: (2023) -
Novel metabolic phenotypes for extrahepatic complication of nonalcoholic fatty liver disease
por: Yi, Jiayi, et al.
Publicado: (2023) -
Retrospective study of gene signatures and prognostic value of m6A regulatory factor in non-small cell lung cancer using TCGA database and the verification of FTO
por: Shi, Hongjie, et al.
Publicado: (2020) -
Tumor stemness and immune infiltration synergistically predict response of radiotherapy or immunotherapy and relapse in lung adenocarcinoma
por: Shi, Hongjie, et al.
Publicado: (2021) -
Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients
por: Liu, Lu, et al.
Publicado: (2017)